Abstract
Iron is critical to the survival of almost all living organisms. However, inappropriately low or high levels of iron are detrimental and contribute to a wide range of diseases. Recent advances in the study of iron metabolism have revealed multiple intricate pathways that are essential to the maintenance of iron homeostasis. Further, iron regulation involves processes at several scales, ranging from the subcellular to the organismal. This complexity makes a systems biology approach crucial, with its enabling technology of computational models based on a mathematical description of regulatory systems. Systems biology may represent a new strategy for understanding imbalances in iron metabolism and their underlying causes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Kell DB. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics. 2009;2:2.
Hower V, et al. A general map of iron metabolism and tissue-specific subnetworks. Mol Biosyst. 2009;5(5):422–43.
Josephs HW. Absorption of iron as a problem in human physiology; a critical review. Blood. 1958;13(1):1–54.
Laufberger V. Sur la cristallisation de la ferritine. Soc Chim Biol. 1937;19:1575–82.
Feder JN, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13(4):399–408.
Trowbridge IS, Omary MB. Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc Natl Acad Sci U S A. 1981;78(5):3039–43.
Hentze MW, Kuhn LC. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci U S A. 1996;93(16):8175–82.
Abboud S, Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem. 2000;275(26):19906–12.
Donovan A, et al. Positional cloning of zebrafish Fpn1 identifies a conserved vertebrate iron exporter. Nature. 2000;403(6771):776–81.
Krause A, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 2000;480(2–3):147–50.
McKie AT, et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell. 2000;5(2):299–309.
Park CH, et al. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276(11):7806–10.
Pigeon C, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001;276(11):7811–9.
Andrews NC. Forging a field: the golden age of iron biology. Blood. 2008;112(2):219–30.
Andrews NC, Schmidt PJ. Iron homeostasis. Annu Rev Physiol. 2007;69:69–85.
Ganz T. Hepcidin and iron regulation, 10 years later. Blood. 2011;117(17):4425–33.
Hentze MW, et al. Two to tango: regulation of mammalian iron metabolism. Cell. 2010;142(1):24–38.
Muckenthaler MU, Galy B, Hentze MW. Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu Rev Nutr. 2008;28:197–213.
De Domenico I, Ward DM, Kaplan J. Hepcidin regulation: ironing out the details. J Clin Invest. 2007;117(7):1755–8.
Gunshin H, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 1997;388(6641):482–8.
Fleming MD, et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet. 1997;16(4):383–6.
Canonne-Hergaux F, et al. Cellular and subcellular localization of the Nramp2 iron transporter in the intestinal brush border and regulation by dietary iron. Blood. 1999;93(12):4406–17.
Oakhill JS, et al. Functional characterization of human duodenal cytochrome b (Cybrd1): redox properties in relation to iron and ascorbate metabolism. Biochim Biophys Acta. 2008;1777(3):260–8.
Turi JL, et al. Duodenal cytochrome b: a novel ferrireductase in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2006;291(2):L272–80.
Ferris CD, et al. Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat Cell Biol. 1999;1(3):152–7.
Arosio P, Levi S. Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage. Biochim Biophys Acta. 2010;1800(8):783–92.
Theil EC. Ferritin: at the crossroads of iron and oxygen metabolism. J Nutr. 2003; 133(5 Suppl 1):1549S–53S.
Vulpe CD, et al. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet. 1999;21(2):195–9.
Schade AL, Caroline L. An Iron-binding component in human blood plasma. Science. 1946;104(2702):340–1.
Ohgami RS, et al. The Steap proteins are metalloreductases. Blood. 2006;108(4):1388–94.
Shaw GC, et al. Mitoferrin is essential for erythroid iron assimilation. Nature. 2006;440(7080):96–100.
Krishnamurthy P, Xie T, Schuetz JD. The role of transporters in cellular heme and porphyrin homeostasis. Pharmacol Ther. 2007;114(3):345–58.
Keel SB, et al. A heme export protein is required for red blood cell differentiation and iron homeostasis. Science. 2008;319(5864):825–8.
Donovan A, et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 2005;1(3):191–200.
Johnson MB, Enns CA. Diferric transferrin regulates transferrin receptor 2 protein stability. Blood. 2004;104(13):4287–93.
Kawabata H, et al. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem. 1999;274(30):20826–32.
Robb A, Wessling-Resnick M. Regulation of transferrin receptor 2 protein levels by transferrin. Blood. 2004;104(13):4294–9.
Liuzzi JP, et al. Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells. Proc Natl Acad Sci U S A. 2006;103(37):13612–7.
Nemeth E, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306(5704):2090–3.
De Domenico I, et al. Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2. Proc Natl Acad Sci U S A. 2009;106(10):3800–5.
Qiao B, et al. Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination. Cell Metab. 2012;15(6):918–24.
Ross SL, et al. Molecular mechanism of hepcidin-mediated ferroportin internalization requires ferroportin lysines, not tyrosines or JAK-STAT. Cell Metab. 2012;15(6):905–17.
Babitt JL, et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet. 2006;38(5):531–9.
Andriopoulos B Jr, et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet. 2009;41(4):482–7.
Meynard D, et al. Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet. 2009;41(4):478–81.
Wang RH, et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab. 2005;2(6):399–409.
Lee DH, et al. Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis. Blood. 2010;115(15):3136–45.
Zhang AS, et al. Hemojuvelin-neogenin interaction is required for bone morphogenic protein-4-induced hepcidin expression. J Biol Chem. 2009;284(34):22580–9.
Silvestri L, et al. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab. 2008;8(6):502–11.
Gao J, et al. Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression. Cell Metab. 2009;9(3):217–27.
Gao J, et al. Hepatocyte-targeted HFE and TFR2 control hepcidin expression in mice. Blood. 2010;115(16):3374–81.
Wallace DF, et al. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload. Hepatology. 2009;50(6):1992–2000.
Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood. 2006;108(9):3204–9.
Pietrangelo A, et al. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. Gastroenterology. 2007;132(1):294–300.
Verga Falzacappa MV, et al. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood. 2007;109(1):353–8.
Andrews NC. Anemia of inflammation: the cytokine-hepcidin link. J Clin Invest. 2004;113(9):1251–3.
Shayeghi M, et al. Identification of an intestinal heme transporter. Cell. 2005;122(5):789–801.
Qiu A, et al. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell. 2006;127(5):917–28.
Andrews NC. When is a heme transporter not a heme transporter? When it’s a folate transporter. Cell Metab. 2007;5(1):5–6.
Rajagopal A, et al. Haem homeostasis is regulated by the conserved and concerted functions of HRG-1 proteins. Nature. 2008;453(7198):1127–31.
Ferreira GC, Gong J. 5-Aminolevulinate synthase and the first step of heme biosynthesis. J Bioenerg Biomembr. 1995;27(2):151–9.
Yoshida T, et al. Human heme oxygenase cDNA and induction of its mRNA by hemin. Eur J Biochem. 1988;171(3):457–61.
Andrews NC. Disorders of iron metabolism. N Engl J Med. 1999;341(26):1986–95.
Allen KJ, et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med. 2008;358(3):221–30.
Roetto A, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet. 2003;33(1):21–2.
Papanikolaou G, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet. 2004;36(1):77–82.
Niederkofler V, Salie R, Arber S. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J Clin Invest. 2005;115(8):2180–6.
Nemeth E, et al. Hepcidin is decreased in TFR2 hemochromatosis. Blood. 2005;105(4):1803–6.
Sham RL, et al. Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326 S ferroportin mutation. Blood. 2009;114(2):493–4.
Harris ZL, et al. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci U S A. 1995;92(7):2539–43.
Yoshida K, et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet. 1995;9(3):267–72.
Beutler E, et al. Molecular characterization of a case of atransferrinemia. Blood. 2000;96(13):4071–4.
Nemeth E, et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101(7):2461–3.
Nemeth E, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113(9):1271–6.
Torti SV, Torti FM. Ironing out cancer. Cancer Res. 2011;71(5):1511–4.
Kotsopoulos J, et al. Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: an exploratory study. Cancer Causes Control. 2012;23(7):1065–74.
Hann HW, Stahlhut MW, Blumberg BS. Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice. Cancer Res. 1988;48(15):4168–70.
Richardson DR. Iron chelators as therapeutic agents for the treatment of cancer. Crit Rev Oncol Hematol. 2002;42(3):267–81.
Faulk WP, Hsi BL, Stevens PJ. Transferrin and transferrin receptors in carcinoma of the breast. Lancet. 1980;2(8191):390–2.
Shan L, et al. Visualizing head and neck tumors in vivo using near-infrared fluorescent transferrin conjugate. Mol Imaging. 2008;7(1):42–9.
Pinnix ZK, et al. Ferroportin and iron regulation in breast cancer progression and prognosis. Sci Transl Med. 2010;2(43):43–56.
Miller LD, et al. An iron regulatory gene signature predicts outcome in breast cancer. Cancer Res. 2011;71(21):6728–37.
Laubenbacher R, et al. A systems biology view of cancer. Biochim Biophys Acta. 2009;1796(2):129–39.
Lao BJ, Kamei DT. A compartmental model of iron regulation in the mouse. J Theor Biol. 2006;243(4):542–54.
Rivera S, et al. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood. 2005;106(6):2196–9.
Hentze MW, Muckenthaler MU, Andrews NC. Balancing acts: molecular control of mammalian iron metabolism. Cell. 2004;117(3):285–97.
Lopes TJ, et al. Systems analysis of iron metabolism: the network of iron pools and fluxes. BMC Syst Biol. 2010;4:112.
Schumann K, et al. A method to assess 59Fe in residual tissue blood content in mice and its use to correct 59Fe-distribution kinetics accordingly. Toxicology. 2007;241(1–2):19–32.
Chifman J, et al. The core control system of intracellular iron homeostasis: a mathematical model. J Theor Biol. 2012;300:91–9.
Epsztejn S, et al. Fluorescence analysis of the labile iron pool of mammalian cells. Anal Biochem. 1997;248(1):31–40.
Formanowicz D, et al. Petri net based model of the body iron homeostasis. J Biomed Inform. 2007;40(5):476–85.
Formanowicz D, et al. Some aspects of the anemia of chronic disorders modeled and analyzed by petri net based approach. Bioprocess Biosyst Eng. 2011;34(5):581–95.
Sackmann A, et al. An analysis of the petri net based model of the human body iron homeostasis process. Comput Biol Chem. 2007;31(1):1–10.
Acknowledgments
This work was supported in part by Grants NIH R21 CA156133–01A1 (R.L., S.V.T.) and NIH Cancer Biology Training Grant T32-CA079448 (J.C.).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chifman, J., Laubenbacher, R., Torti, S. (2014). A Systems Biology Approach to Iron Metabolism. In: Corey, S., Kimmel, M., Leonard, J. (eds) A Systems Biology Approach to Blood. Advances in Experimental Medicine and Biology, vol 844. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2095-2_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2095-2_10
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2094-5
Online ISBN: 978-1-4939-2095-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)